↓ Skip to main content

Cochrane Database of Systematic Reviews

Interferon beta for secondary progressive multiple sclerosis

Overview of attention for article published in Cochrane database of systematic reviews, January 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news
1 news outlet
blogs
2 blogs
twitter
3 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
70 Dimensions

Readers on

mendeley
116 Mendeley
Title
Interferon beta for secondary progressive multiple sclerosis
Published in
Cochrane database of systematic reviews, January 2012
DOI 10.1002/14651858.cd005181.pub3
Pubmed ID
Authors

Loredana La Mantia, Laura Vacchi, Carlo Di Pietrantonj, George Ebers, Marco Rovaris, Sten Fredrikson, Graziella Filippini

Abstract

Therapy with either recombinant beta-1a or beta-1b interferons (IFNs) is worldwide approved for Relapsing Remitting Multiple Sclerosis (RRMS). A major unanswered question is whether this treatment is able to safely reverse or retard the progressive phase of the disease.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 116 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 2%
Turkey 1 <1%
France 1 <1%
Unknown 112 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 21 18%
Student > Master 19 16%
Researcher 15 13%
Other 10 9%
Student > Postgraduate 10 9%
Other 19 16%
Unknown 22 19%
Readers by discipline Count As %
Medicine and Dentistry 50 43%
Psychology 8 7%
Social Sciences 6 5%
Agricultural and Biological Sciences 6 5%
Neuroscience 5 4%
Other 14 12%
Unknown 27 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 August 2019.
All research outputs
#981,423
of 17,349,416 outputs
Outputs from Cochrane database of systematic reviews
#2,572
of 11,660 outputs
Outputs of similar age
#9,276
of 224,307 outputs
Outputs of similar age from Cochrane database of systematic reviews
#98
of 499 outputs
Altmetric has tracked 17,349,416 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,660 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.9. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 224,307 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 499 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.